CNN Brain Age Estimation with Saliency Maps

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Current deep learning models for estimating biological brain age from MRI data lack neuroanatomic interpretability and generalizability, leading to poor performance on new data and inadequate early identification of Alzheimer's disease risk.

Innovation Solution

A convolutional neural network (CNN) is developed to estimate biological brain age by generating interpretable saliency maps from T1-weighted brain MRIs, providing detailed anatomic maps of brain aging patterns and sex dimorphisms, and updating the model based on training objectives using cognitively normal brain data sets.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Measurement precision

If deep learning models are used to estimate biological brain age from MRI data, then estimation capability is improved, but neuroanatomic interpretability deteriorates

Engineering Contradiction:
Improvebrain age estimation accuracyVSAvoidneuroanatomic interpretability
Core Design Contradiction:
Measurement precisionVSLoss of information

Solution Approach 1:

The patent introduces saliency maps as an intermediary between the deep learning model and the input MRI data. These maps visually highlight the brain regions that most influence the age estimation, providing neuroanatomic interpretability without compromising the model's estimation accuracy. The saliency maps serve as a mediator that translates the black-box model decisions into interpretable anatomical patterns.

Inventive Principle:
Principle #24Intermediary (Mediator)

2Measurement precision

If deep learning models are used to estimate biological brain age, then estimation capability is improved, but generalizability to new data deteriorates

Engineering Contradiction:
Improvebrain age estimation accuracyVSAvoidgeneralizability
Core Design Contradiction:
Measurement precisionVSReliability

Solution Approach 1:

The patent performs preliminary actions by extensively preprocessing the training data to account for variations in scanning protocols, demographics, and cognitive statuses. The model is trained on diverse data from multiple cohorts with different characteristics, preparing it in advance to handle new, unseen data. This preliminary exposure to variability improves generalizability while maintaining estimation accuracy.

Inventive Principle:
Principle #10Preliminary action

3Speed

If current deep learning models are used, then processing speed is improved, but early identification of Alzheimer's disease risk deteriorates

Engineering Contradiction:
Improveprocessing speedVSAvoidAlzheimer's disease risk identification accuracy
Core Design Contradiction:
SpeedVSMeasurement precision

Solution Approach 1:

The patent applies local quality by focusing the analysis on specific brain regions and patterns that are locally relevant to Alzheimer's disease pathology. The saliency maps highlight localized anatomical changes in regions known to be affected early in AD, such as the hippocampus and cortical areas. This region-specific focus improves early risk identification while maintaining efficient processing through targeted analysis rather than whole-brain examination.

Inventive Principle:
Principle #3Local quality

Data Source

PatentUS20250104240A1Personalized profiling of future brain trajectories and future disease evolution using generative artificial intelligence
Publication Date: 2025.03.27 UNIV OF SOUTHERN CALIFORNIA
  • US20250104240A1 patent drawing
  • US20250104240A1 patent drawing
  • US20250104240A1 patent drawing

AI summary

A system, method, and device (“system”) is provided for conducting anatomically interpretable deep learning of brain age that captures domain-specific cognitive impairment. By performing personalized profiling of future brain trajectories using generative artificial intelligence, the system facilitates early identification of neuroanatomy changes to screen individuals according to risk of neurocognitive impairments. A system may implement a generative AI model and may receive a plurality of brain data sets, extract various maps of a subject brain, and determine a salience probability map of future brain trajectory or future brain disease biomarkers based thereon. Moreover, the generative AI model may compute a training objective and the model may update based on the training objective.